Abstract
Onychomycosis is a common chronic-resistant nail disease. Traditional treatment has its limitations and side effects. This study aimed to evaluate the role of fractional CO2 laser and topical tioconazole 28% nail lacquer in the treatment of fingernail onychomycosis, as sole treatment modalities and in combination. Thirty patients with culture-proven onychomycosis were included and randomly divided into three equal groups. Laser group received six fractional carbon dioxide (CO2) laser sessions at monthly intervals; topical group received topical tioconazole 28% nail lacquer twice daily for 6 months, and combined group received six fractional CO2 laser sessions at monthly intervals with topical tioconazole twice daily for 6 months. Treatment outcome was evaluated through physician’s evaluation of improvement using onychomycosis severity index score (OSI), patients’ satisfaction, side effect evaluation, and mycological culture (assessed after the end of treatment). At the end of treatment, both laser and combined groups showed significantly better degrees of improvement (P = 0.036, 0.024, respectively) and patient’s satisfaction (P = 0.046, 0.003, respectively) in comparison with topical group. Mycological clearance in fungal cultures was significantly higher in combined group than topical group after the end of treatment (P = 0.007). Fractional CO2 laser is a safe and effective treatment modality for onychomycosis. Its efficacy approximates that of fractional CO2 laser combined with topical tioconazole 28% nail lacquer and surpasses that of topical tioconazole 28% monotherapy. It is expected to be an excellent choice for patients in whom systemic antifungals are contraindicated or who are unresponsive or intolerant to topical antifungals.
Similar content being viewed by others
References
Kim DM, Suh MK, Ha GY, Sohng SH (2012) Fingernail onychomycosis due to Aspergillus Niger. Ann Dermatol 24:459–463
Elewski BE, Tosti A (2015) Risk factors and comorbidities for onychomycosis: implications for treatment with topical therapy. J Clin Aesthet Dermatol 8(11):38–42
Hay RJ, Baran R (2011) Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol 65(6):1219–1227
Rosen T, Stein Gold LF (2016) Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action. Semin Cutan Med Surg 35(3):S51–S55
Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A (2018) Global perspectives for the management of onychomycosis. Int J Dermatol. https://doi.org/10.1111/ijd.14346
Zhang RN, Wang DK, Zhuo FL, Duan XH, Zhang XY, Zhao JY (2012) Long-pulse Nd:YAG 1064-nm laser treatment for onychomycosis. Chin Med J 125:3288–3291
Gupta AK, Simpson FC, Heller DF (2016) The future of lasers in onychomycosis. J Dermatolog Treat 27:167–172
Helou J, Maatouk I, Hajjar MA, Moutran R (2016) Evaluation of Nd:YAG laser device efficacy on onychomycosis: a case series of 30 patients. Mycoses 59:7–11
Lim EH, Kim HR, Park YO, Lee Y, Seo YJ, Kim CD et al (2014) Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol 70(5):918–923
Kozarev J, Vizintin Z (2010) Novel laser therapy in treatment of onychomycosis. J Laser Health Acad 1:1–9
Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y (2008) Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol 144(1):19–21
Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR (2008) Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol 158(6):1239–1246
Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J et al (2011) A new classification system for grading the severity of onychomycosis: onychomycosis severity index. Arch Dermatol 147(11):1277–1282
Shi J, Li J, Huang H, Permatasari F, Liu J, Xu Y et al (2017) The efficacy of fractional carbon dioxide (CO2) laser combined with terbinafine hydrochloride 1% cream for the treatment of onychomycosis. J Cosmet Laser Ther 19(6):353–359
Hay RJ, Mackie RM, Clayton YM (1985) Tioconazole nail solution—an open study of its efficacy in onychomycosis. Clin Exper Dermatol 10(2):111–115
Baran R, Kaoukhov A (2005) Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol 19(1):21–29
Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V et al (2009) An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 23(7):773–781
Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H et al (2013) Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol 68(4):600–608
Bhatta AK, Keyal U, Huang X, Zhao JJ (2016) Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. J Am Acad Dermatol 74:916–923
Zhou BR, Lu Y, Permatasari F, Huang H, Li J, Liu J et al (2016) The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: a randomized, controlled trial. Medicine 95(44):e5141
Abd El-Aal EB, Abdo HM, Ibrahim SM, Eldestawy MT (2018) Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. J Dermatolog Treat 28:1–6
Yang Y, Liu H, Yang R, Huang X, Jing D, Wang L (2015) Efficacy of a superpulse-mode fractional carbon dioxide laser for the treatment of onychomycosis: a clinical observational study. Chinese J Dermatol 48(8):526–530
Hira K, Yamada H, Takahashi Y, Ogawa H (2002) Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol 16:273–275
Alam M, Pantanowitz L, Harton AM, Arndt KA, Dover JS (2003) A prospective trial of fungal colonization after laser resurfacing of the face: correlation between culture positivity and symptoms of pruritus. Dermatol Surg 29:255–260
Borovoy M, Tracy M (1992) Noninvasive CO 2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon 10:123–124
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
El-Tatawy, R.A., Aliweh, H.A., Hegab, D.S. et al. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci 34, 1873–1880 (2019). https://doi.org/10.1007/s10103-019-02789-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-019-02789-2